August 31, 2023 07:23 AM EDT

Sage shrinks workforce by 40% in light of major depression drug rejection

Kyle LaHucik

Biotech Correspondent

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Summit’s disappointing survival readout raises stakes for full data

Summit says bispecific misses overall survival in closely-watched lung cancer study

Another Bristol Myers exec goes to Acadia; David Southwell takes CEO job at ARCH-backed cancer biotech

HHS says it's pulled Covid shot guidance for healthy kids. The CDC vaccine schedule shows otherwise

Sanofi, Regeneron report underwhelming COPD data for IL-33 antibody, shares drop

sponsored

From weeks to days: how Aizon Intelligent Agents transform pharma validation